AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 80 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $29,000 | -61.3% | 12,680 | -19.6% | 0.00% | – |
| Q4 2021 | $75,000 | -39.5% | 15,771 | +0.7% | 0.00% | – |
| Q3 2021 | $124,000 | -7.5% | 15,658 | -18.8% | 0.00% | – |
| Q2 2021 | $134,000 | -9.5% | 19,293 | +3.2% | 0.00% | – |
| Q1 2021 | $148,000 | +8.0% | 18,697 | +7.5% | 0.00% | -100.0% |
| Q4 2020 | $137,000 | +57.5% | 17,400 | +41.0% | 0.00% | – |
| Q3 2020 | $87,000 | -26.9% | 12,337 | -3.9% | 0.00% | -100.0% |
| Q2 2020 | $119,000 | +43.4% | 12,831 | +18.8% | 0.00% | – |
| Q3 2019 | $83,000 | +15.3% | 10,801 | +3.3% | 0.00% | – |
| Q2 2019 | $72,000 | -21.7% | 10,452 | -8.4% | 0.00% | -100.0% |
| Q1 2019 | $92,000 | – | 11,406 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 279,678 | $2,587,000 | 10.00% |
| Aisling Capital Management LP | 1,691,151 | $15,643,000 | 5.97% |
| Samsara BioCapital, LLC | 967,500 | $8,949,000 | 2.88% |
| Bain Capital Life Sciences Investors, LLC | 2,700,000 | $24,975,000 | 2.62% |
| Soleus Capital Management, L.P. | 369,852 | $3,421,000 | 1.95% |
| Nantahala Capital Management | 3,204,830 | $29,645,000 | 0.89% |
| Lion Point Capital, LP | 300,000 | $2,775,000 | 0.67% |
| Abingworth LLP | 240,500 | $2,221,000 | 0.62% |
| Sio Capital Management, LLC | 211,104 | $1,953,000 | 0.57% |
| Orbimed Advisors | 4,015,524 | $37,144,000 | 0.52% |